Mary Anne Fenton

Functional characterization of mutant androgen receptors from androgen-independent prostate cancer.

Mary Anne Fenton, Todd D. Shuster, Andra Fertig et al. · PubMed · 1997 · 228 citations

Molecular Pharmacology, Androgen Receptor, Urology +15

HIGH DOSE BICALUTAMIDE FOR ANDROGEN INDEPENDENT PROSTATE CANCER: EFFECT OF PRIOR HORMONAL THERAPY

Robin Joyce, Mary Anne Fenton, P Rode et al. · The Journal of Urology · 1998 · 206 citations

Immune Signatures Following Single Dose Trastuzumab Predict Pathologic Response to PreoperativeTrastuzumab and Chemotherapy in HER2-Positive Early Breast Cancer

Vinay Varadan, Hannah Gilmore, Kristy Miskimen et al. · Clinical Cancer Research · 2016 · 114 citations · Full text

Frequent Pathologic Complete Responses in Aggressive Stages II to III Breast Cancers With Every-4-Week Carboplatin and Weekly Paclitaxel With or Without Trastuzumab: A Brown University Oncology Group Study

William M. Sikov, Don S. Dizon, Rochelle Strenger et al. · Journal of Clinical Oncology · 2009 · 108 citations · Full text

Identification of stromal ColXα1 and tumor-infiltrating lymphocytes as putative predictive markers of neoadjuvant therapy in estrogen receptor-positive/HER2-positive breast cancer

Alexander S. Brodsky, Jinjun Xiong, Dongfang Yang et al. · BMC Cancer · 2016 · 45 citations · Full text